Sugammadex

Sugammadex (Bridion; Merck & Co. Inc, Whitehouse Station, NJ), was approved in December 2015 for reversal of neuromuscular blockade from rocuronium and vecuronium in adults undergoing surgery. References

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of perianesthesia nursing 2016-08, Vol.31 (4), p.354-357
1. Verfasser:	Golembiewski, Julie
Format:	Artikel
Sprache:	eng
Schlagworte:	gamma-Cyclodextrins - administration & dosage gamma-Cyclodextrins - pharmacokinetics gamma-Cyclodextrins - therapeutic use Humans Neuromuscular Blockade Nursing Randomized Controlled Trials as Topic
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Sugammadex (Bridion; Merck & Co. Inc, Whitehouse Station, NJ), was approved in December 2015 for reversal of neuromuscular blockade from rocuronium and vecuronium in adults undergoing surgery. References
ISSN:	1089-9472 1532-8473
DOI:	10.1016/j.jopan.2016.05.004